[{"Assets_0_Q3_USD":194061000.0,"CommonStockSharesOutstanding_0_Q3_shares":60250094.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-7550000.0,"NetIncomeLoss_1_Q3_USD":-8083000.0,"NetIncomeLoss_3_Q3_USD":-61766000.0,"StockholdersEquity_0_Q3_USD":186068000.0,"Ticker":"MYOV","CIK":"1679082","name":"MYOVANT SCIENCES LTD.","OfficialName":"Myovant Sciences Ltd. Common Shares","form":"10-Q","period":"20161231","fy":"2016.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1001965304.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20170213"}]